[Wound management with enzyme alginogels : Expert consensus].
BACKGROUND
The challenges of modern wound management, such as the treatment of chronic wounds and their phase-specific handling, are demanding and require optimally adapted therapeutic measures. The principles of moist wound care as well as an adequate debridement have priority here. To support these necessary measures, different options are available, e.g., a new product group operating across several wound phases.


OBJECTIVE
A new treatment principle in modern wound management based on an expert consensus is presented.


METHODS
On the basis of clinical experience reports and published evidence, the current and new principles of wound treatment were discussed in a panel of experts and formulated as a consensus statement.


RESULTS
Enzyme alginogels represent a combination of agents that allow phase-specific wound care. They exhibit autolytic, absorbent, and antimicrobial properties and simultaneously cover three components of wound management based on the TIME framework. Thus, according to the experts, they differ from other wound healing products and can be classified in a distinct product group. Clinical studies, as well as clinical experiences, provide evidence for the efficacy of enzyme alginogels.


CONCLUSIONS
According to the experts, the potential of enzyme alginogels used considering the principles of moist wound care, comprises the three-fold effect (continuous and significantly simplified debridement, maintaining a moist wound environment and antimicrobial effect without cytotoxicity), the ease of use, and the flexible application. In addition, the flexibility of the product class regarding frequency of application, duration of treatment and combinability with secondary dressings, are of economic benefit in the health care sector.
Abteilung für Dermatologie und Venerologie, LKH Feldkirch, Akademisches Lehrspital, Carinagasse 45-47, 6800, Feldkirch, Österreich. robert.strohal@lkhf.at.
R
R
Strohal
Arbeitsgruppe Dekubitus/Wundpflege, Universitätsklinikum Tübingen, Geissweg 3, 72076, Tübingen, Deutschland.|Initiative Chronische Wunden e. V., Pölle 27/28, 06484, Quedlinburg, Deutschland.
B
B
Assenheimer
Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.
M
M
Augustin
Wundambulanz, LKH Bregenz, Carl-Pedenz-Str. 2, 6900, Bregenz, Österreich.
G
G
Hämmerle
Dermatologische Klinik, Universitätsspital Zürich, Gloriastr. 31, 8091, Zürich, Schweiz.
S
S
Läuchli
Gemeinschaftspraxis für Allgemeinmedizin, Bahnhofstr. 18, 26180, Rastede, Deutschland.
B
B
Pundt
Ambulantes-Therapie-Zentrum ATZ Stern, Barloer Weg 127b, 46397, Bocholt, Deutschland.
G
G
Stern
Klinik für Gefäß- und Thoraxchirurgie, Städt. Klinikum Karlsruhe, Moltkestr. 90, 76133, Karlsruhe, Deutschland.
M
M
Storck
Klinik für Dermatologie, Venerologie und Allergologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
C
C
Ulrich
D000464:Alginates / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001458:Bandages; D003131:Combined Modality Therapy / Q000379:methods / Q000592:standards; D003646:Debridement / Q000379:methods / Q000592:standards*; D003880:Dermatology / Q000592:standards*; D019317:Evidence-Based Medicine; D005104:Expert Testimony / Q000592:standards*; D005858:Germany; D006801:Humans; D022125:Lacerations / Q000175:diagnosis / Q000628:therapy; D010088:Oxidoreductases / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*
D000464:Alginates; D000900:Anti-Bacterial Agents; D010088:Oxidoreductases
Application; Chronic wounds; Debridement; Treatment; Wound healing
Exp Dermatol. 2011 Mar;20(3):229-31
21323744
Curr Diab Rep. 2001 Dec;1(3):233-8
12643204
Nature. 1963 Oct 26;200:377-8
14087904
J Wound Care. 2005 Feb;14(2):59-61
15739652
Enzyme Res. 2014;2014:517164
25309750
Int J Low Extrem Wounds. 2006 Jun;5(2):109-14
16698915
J Wound Care. 2013 Jan;22(1):5
23299351
J Biol Chem. 1969 Jul 10;244(13):3625-34
5794229
Wounds. 2010 Jun;22(6):161-4
25901464
J Wound Care. 2014 May;23 (5):278, 280-2, 284-5
24810313
Lancet. 2001 Jul 14;358(9276):135-8
11463434
Wound Repair Regen. 2008 Jan-Feb;16(1):37-44
18086294
Br J Nutr. 2000 Nov;84 Suppl 1:S19-25
11242442
J Invest Dermatol. 2002 Dec;119(6):1420-5
12485449
Wounds. 2009 Mar;21(3):65-73
25903028
Int Wound J. 2013 Dec;10(6):630-7
23672196
Nature. 2009 Jun 18;459(7249):996-9
19494811
FEBS J. 2012 May;279(9):1632-9
22093282
Wound Repair Regen. 1999 Nov-Dec;7(6):442-52
10633003
Hautarzt. 2003 Oct;54(10):959-65
14513243
J Wound Care. 2012 Jan;21(1):22, 24-8
22240929
Nature. 1962 Jan 20;193:293-4
14007593
Mol Med Rep. 2012 Oct;6(4):723-8
22798012
J Dtsch Dermatol Ges. 2014 Jul;12(7):541-54
24813380
J Eur Acad Dermatol Venereol. 2006 Feb;20(2):131-5
16441618